Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation
Clinical trial NCT02002988 · UNKNOWN
Trial details
- NCT number
- NCT02002988
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.